Explore more publications!

Telecoms Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Telecoms Today.

Press releases published on October 6, 2025

Interfor to Announce Third Quarter Results on November 6, 2025
Bombardier mène à bien le rachat de la totalité de ses billets de premier rang 7,125 % échéant en 2026 et le rachat partiel de ses billets de premier rang 7,875 % échéant en 2027 d’un capital de 83 711 000 $ US
Bombardier Completes Redemption for All of its 7.125% Senior Notes due 2026 and Partial Redemption for US$83,711,000 of its 7.875% Senior Notes due 2027
Parler Cloud Technologies and Kyvo Launch Global “Invite & Earn” Program — Rewarding Users and Their Referrals with 500 OPT Tokens Each
SPX Technologies to Report Third Quarter 2025 Financial Results
Dyne Therapeutics Announces Additional One-Year Clinical Data Demonstrating Functional Improvement from Phase 1/2 ACHIEVE Trial of Zeleciment Basivarsen (DYNE-101) for Myotonic Dystrophy Type 1 (DM1)
Savara Inc. INVESTOR ALERT: Kirby McInerney LLP Reminds Savara Inc. Investors of Looming Lead Plaintiff Deadline in Class Action Lawsuit
Billor Establishes New Headquarters in Raleigh, North Carolina
Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
FOBI AI ANNOUNCES LAUNCH OF “FOBI AI 3.0” — STRATEGY. ARCHITECTURE. EXECUTION.
DBV Technologies Announces Sale of approximately $30 million of ADSs Through its At-The-Market (ATM) Program on Nasdaq
DBV Technologies annonce un placement d’ADS pour un montant d’environ 30 millions de Dollars US dans le cadre de son programme At-The-Market (ATM) sur le Nasdaq
NowVertical Retires Debentures in Full, Strengthening Balance Sheet
Helium Evolution Announces Start-Up of Soda Lake Helium Purification Facility
AbraSilver Announces $43.4 Million “Bought Deal” Life Private Placement to Advance Diablillos Project
CPS Technologies Corp. Announces Proposed Public Offering of Common Stock
Lithium Argentina to Release Third Quarter 2025 Results on November 10, 2025
Rocket Lab Sets Launch Schedule for 1st of 21 New Missions with Synspective
Counterpart Health Expands Leadership to Accelerate Enterprise Partnerships and Regional Adoption of AI-Powered Platform Counterpart Assistant
Eisai and Biogen Announce U.S. Availability of LEQEMBI® IQLIK™ (lecanemab-irmb) Subcutaneous Injection Maintenance Dose for Treatment of Early Alzheimer’s Disease

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions